Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)

NCT06160284 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT06160284
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06160284 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of Synaptotrophic Effects of Psilocybin in Opioid Use Disorder (OUD)
Lead sponsor
Yale University
Phase
Phase 1
Overall status
Recruiting
Start date
May 28, 2025
Completion date
January 31, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

opioid use disorder